Rezolute And 2 Other Penny Stocks Insiders Are Aggressively Buying

The Dow Jones closed lower by over 300 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

BioCorRx

• The Trade: BioCorRx Inc. BICX Director Joseph J Galligan acquired a total 184,780 shares an average price of $1.75. To acquire these shares, it cost around $299,768.
• What’s Happening: BioCorRx recently provided a business update for the three months ended March 31, 2023.
• What BioCorRx Does: BioCorRx Inc through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders.

Rezolute

• The Trade: Rezolute, Inc. RZLT Chief Medical Officer Brian Kenneth Roberts acquired a total of 5,000 shares at an average price of $1.90. The insider spent around $9,500.
• What’s Happening: Rezolute recently announced plans to initiate a pivotal Phase 3 study of RZ358 in participants 3 months of age and older with congenital hyperinsulinism.
• What Rezolute Does: Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies.

Cadiz

• The Trade: Cadiz Inc. CDZI 10% owner Heerema International Group Services SA acquired a total of 200,000 shares at an average price of $4.00. To acquire these shares, it cost around $800,000.
• What’s Happening: Cadiz recently partnered with Scale Microgrids to develop clean energy microgrids for water supply, pipeline project.
• What Cadiz Does: Cadiz Inc is a land and water resource development company in California.

Check This Out: Investor Sentiment Drops Following Economic Reports

Don’t forget to check out our premarket coverage here